Correlation Between Keros Therapeutics and Kalvista Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Keros Therapeutics and Kalvista Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Keros Therapeutics and Kalvista Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Keros Therapeutics and Kalvista Pharmaceuticals, you can compare the effects of market volatilities on Keros Therapeutics and Kalvista Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Keros Therapeutics with a short position of Kalvista Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Keros Therapeutics and Kalvista Pharmaceuticals.
Diversification Opportunities for Keros Therapeutics and Kalvista Pharmaceuticals
0.29 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Keros and Kalvista is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding Keros Therapeutics and Kalvista Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kalvista Pharmaceuticals and Keros Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Keros Therapeutics are associated (or correlated) with Kalvista Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kalvista Pharmaceuticals has no effect on the direction of Keros Therapeutics i.e., Keros Therapeutics and Kalvista Pharmaceuticals go up and down completely randomly.
Pair Corralation between Keros Therapeutics and Kalvista Pharmaceuticals
Given the investment horizon of 90 days Keros Therapeutics is expected to under-perform the Kalvista Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Keros Therapeutics is 1.37 times less risky than Kalvista Pharmaceuticals. The stock trades about -0.06 of its potential returns per unit of risk. The Kalvista Pharmaceuticals is currently generating about 0.33 of returns per unit of risk over similar time horizon. If you would invest 877.00 in Kalvista Pharmaceuticals on November 30, 2024 and sell it today you would earn a total of 209.00 from holding Kalvista Pharmaceuticals or generate 23.83% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Keros Therapeutics vs. Kalvista Pharmaceuticals
Performance |
Timeline |
Keros Therapeutics |
Kalvista Pharmaceuticals |
Keros Therapeutics and Kalvista Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Keros Therapeutics and Kalvista Pharmaceuticals
The main advantage of trading using opposite Keros Therapeutics and Kalvista Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Keros Therapeutics position performs unexpectedly, Kalvista Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kalvista Pharmaceuticals will offset losses from the drop in Kalvista Pharmaceuticals' long position.Keros Therapeutics vs. Ideaya Biosciences | ||
Keros Therapeutics vs. AnaptysBio | ||
Keros Therapeutics vs. MeiraGTx Holdings PLC | ||
Keros Therapeutics vs. Janux Therapeutics |
Kalvista Pharmaceuticals vs. Crinetics Pharmaceuticals | ||
Kalvista Pharmaceuticals vs. Kura Oncology | ||
Kalvista Pharmaceuticals vs. Viridian Therapeutics | ||
Kalvista Pharmaceuticals vs. Replimune Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Complementary Tools
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |